Insider reported a trade at Medpace Holdings, Inc.

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Invesco S&P MidCap Quality ETF (Symbol: XMHQ) where we have detected an approximate $427.8 million dollar outflow -- that's a 7.4% decrease week

Notable ETF Outflow Detected - XMHQ, MEDP, MANH, NVT

In the closing of the recent trading day, Medpace (MEDP) stood at $622.11, denoting a +1% move from the preceding trading day.

Medpace (MEDP) Rises As Market Takes a Dip: Key Facts

CON vs. MEDP: Which Stock Is the Better Value Option?

CON or MEDP: Which Is the Better Value Stock Right Now?

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, Asia, South America, Africa, and Australia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.

Medpace Holdings, Inc. News